ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
69,828.58
-0.43%
S&P 500
5,321.41
0.25%
Dow Jones
39,872.99
0.17%
US Dollar vs Yen
156.39
0.09%
Brent Oil
82.06
-0.47%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Scopus BioPharma Inc (SCPS)

  7. Scopus BioPharma Inc (SCPS) ニュース

SCPS

Scopus BioPharma (SCPS)

Scopus BioPharma Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:SCPS
日付受信時刻ニュースソース見出しコード企業名
2023/11/0222 : 15GlobeNewswire Inc.Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of CancerNASDAQ:SCPSScopus BioPharma Inc
2023/06/2906 : 16Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:SCPSScopus BioPharma Inc
2023/05/1306 : 16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SCPSScopus BioPharma Inc
2023/04/2906 : 05Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:SCPSScopus BioPharma Inc
2023/04/1506 : 01Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SCPSScopus BioPharma Inc
2022/12/1620 : 06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
2022/12/0307 : 17Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:SCPSScopus BioPharma Inc
2022/11/2207 : 17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SCPSScopus BioPharma Inc
2022/11/1607 : 16Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:SCPSScopus BioPharma Inc
2022/11/1023 : 15GlobeNewswire Inc.Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — Announces Key Scientific Data to be Presented at the 37th Annual Meeting and Exposition of the Society for Immunotherapy of CancerNASDAQ:SCPSScopus BioPharma Inc
2022/10/1822 : 25GlobeNewswire Inc.Scopus Biopharma Completes Recapitalization Designed To Enhance Shareholder ValueNASDAQ:SCPSScopus BioPharma Inc
2022/09/0306 : 16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
2022/05/2806 : 46Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
2022/05/2006 : 16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SCPSScopus BioPharma Inc
2022/05/1406 : 17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
2022/05/0521 : 30GlobeNewswire Inc.Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of DirectorsNASDAQ:SCPSScopus BioPharma Inc
2022/05/0506 : 17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
2022/05/0305 : 47Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:SCPSScopus BioPharma Inc
2022/04/3006 : 38Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
2022/04/1605 : 18Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SCPSScopus BioPharma Inc
2022/04/0906 : 16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
2022/04/0206 : 17Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:SCPSScopus BioPharma Inc
2022/03/2506 : 17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
2022/03/2319 : 31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
2022/03/2309 : 30GlobeNewswire Inc.Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 3rd Annual STING & TLR-Targeting Therapies SummitNASDAQ:SCPSScopus BioPharma Inc
2022/03/0507 : 17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
2022/02/1907 : 17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
2022/01/2107 : 17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPSScopus BioPharma Inc
2022/01/2022 : 35Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:SCPSScopus BioPharma Inc
2022/01/1920 : 07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SCPSScopus BioPharma Inc
 Showing the most relevant articles for your search:NASDAQ:SCPS

最近閲覧した銘柄

NYSE
BAC
Bank of America
AMEX
XLV
Health Care Select Sector
NYSE
NKE
Nike
USI
USTECH100
US Tech 100
PM
XAUUSD
Gold vs US Dollar
NYSE
KO
Coca Cola
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
NVDA
NVIDIA
AMEX
SPY
SPDR S&P 500
USOTC
BNPQY
BNP Paribas (QX)
NYSE
JPM
JP Morgan Chase
NASDAQ
GOOGL
Alphabet
USOTC
BASFY
BASF (QX)
NYSE
CVX
Chevron
NASDAQ
MSFT
Microsoft
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有